Medicare Part D drug Data year 2024 Brand name Source: CMS Part D Prescribers

Brukinsa

Zanubrutinib

Open in the dashboard

Part D claims

110,650

Prescriptions dispensed, refills included

Drug cost

$1,460,269,190

Paid at the pharmacy, in all

Prescribers

3,905

With 11 or more claims of it

In 2024, Medicare Part D recorded 110,650 claims for Brukinsa (zanubrutinib) from 3,905 prescribers, at a total drug cost of $1.5 billion paid at the pharmacy by Medicare, patients and others.

Where it is prescribed

By the prescriber's state · 54 states and territories
Part D claims for Brukinsa by the state of the prescriber, 2024
State Relative to the most Prescribers Claims Drug cost
CA 466 13,982 $175,361,652
NY 258 9,186 $123,451,141
FL 304 8,646 $114,967,738
TX 215 5,651 $76,179,149
OH 167 5,192 $70,580,976
PA 196 5,113 $67,034,081
MA 126 4,496 $58,523,403
IL 141 4,327 $59,390,899
MI 113 3,122 $41,222,170
NC 103 2,986 $39,162,610
GA 108 2,863 $38,189,628
NJ 94 2,765 $37,825,999
MO 93 2,688 $35,960,872
VA 97 2,591 $35,080,933
WA 104 2,449 $32,279,022
The other 39 states and territories
State Prescribers Claims Drug cost
IN 96 2,387 $30,907,439
MD 82 2,194 $29,596,832
AZ 82 2,051 $26,729,986
TN 74 2,039 $25,432,296
WI 76 1,948 $26,183,838
OR 55 1,892 $24,701,735
SC 58 1,870 $24,647,313
CO 65 1,828 $24,150,262
AL 60 1,648 $22,179,542
MN 68 1,642 $20,393,894
KY 52 1,492 $19,579,691
CT 56 1,445 $19,045,329
LA 49 1,168 $15,601,941
KS 37 1,057 $14,355,677
NV 35 831 $10,966,422
IA 34 805 $10,462,249
AR 33 797 $10,942,298
OK 27 738 $9,480,163
NE 29 647 $7,969,095
NH 20 614 $8,392,846
UT 25 588 $8,135,829
DC 18 534 $7,384,770
ID 17 524 $7,143,333
MS 21 450 $6,021,590
RI 15 404 $5,208,396
ME 12 377 $5,368,687
WV 18 369 $4,841,168
SD 14 368 $4,941,275
MT 17 356 $4,163,198
NM 13 328 $4,165,650
HI 15 327 $4,444,935
VT 9 264 $3,530,394
DE 11 227 $2,779,750
ND 11 176 $2,184,373
PR 8 100 $1,533,973
AK 4 47 $737,839
WY 2 35 $507,465
XX 1 15 $174,159
GU 1 11 $73,284

The state is where the prescriber practices, not where the patient lives. Totals are Medicare Part D claims only.

Which specialties prescribe it

Top 15 of 22
Part D claims for Brukinsa by prescriber specialty, 2024
Specialty Relative to the most Prescribers Claims Drug cost
Hematology-Oncology 2,271 62,685 $832,900,221
Medical Oncology 578 15,905 $210,829,602
Nurse Practitioner 449 12,904 $169,638,168
Internal Medicine 230 6,371 $79,887,916
Hematology 172 6,237 $81,936,354
Physician Assistant 145 4,756 $62,075,114
Hematopoietic Cell Transplantation and Cellular Therapy 19 635 $8,709,137
Pharmacist 13 618 $7,200,449
Hospitalist 8 187 $2,598,038
Certified Clinical Nurse Specialist 4 71 $941,458
Geriatric Medicine 1 47 $619,532
Student in an Organized Health Care Education/Training Program 3 39 $498,018
Radiation Oncology 2 38 $544,910
Family Practice 1 33 $355,632
Hospice and Palliative Care 2 33 $340,975

Specialty is the one printed on each prescriber's Medicare claims.

Largest prescribers

First 5 of 100 by claims · 2024

Two separate records. Claims come from Medicare and related payments from Open Payments. They are shown in one row because they name the same product; they do not show that a payment affected a prescription.

The prescribers with the most Part D claims of this drug in 2024
Prescriber Specialty State Claims Drug cost Related payments
Leslie Rudolph Physician Assistant NY 667 $8,724,899 $900
Lori Leslie Hematology-Oncology NJ 458 $6,421,717 $30,996
Catherine Flynn Nurse Practitioner MA 382 $5,039,009 None on record
Jennifer Greenfield Nurse Practitioner IL 321 $4,704,686 None on record
Shayna Sarosiek Hematology MA 301 $3,895,446 None on record

"No profile" means the prescriber has no Open Payments record here; "None on record" means no payment naming this product in the payment year. Related payments are general payments, and one that names several products is split evenly, so an amount is payments related to the product, not money paid for it. The list is the prescribers with the most claims, up to 100 per drug.

See more in the dashboard: 25 with a free account, all 100 with Patron

Industry payments naming this drug

From CMS Open Payments

Open Payments names products as manufacturers reported them, and CMS does not link them to Part D drugs, so this match is by name and ours. The two records are separate: they do not show that a payment affected a prescription.

What this means

Medicare Part D is the part of Medicare that covers prescription drugs dispensed at a pharmacy. Each year CMS publishes, for every prescriber and drug, how many claims were dispensed and what they cost. This page adds those up for one drug.

A claim is one prescription filled, refills included. Drug cost is the total paid at the pharmacy by Medicare, the patient and anyone else; it is not money to the prescriber. CMS leaves out any prescriber with fewer than 11 claims of a drug, so the prescriber count is a floor and a missing prescriber does not mean none.

Part D covers drugs dispensed to Medicare beneficiaries at a pharmacy. It does not include drugs given in a clinic or hospital, patients with other insurance, or the most recent year, which Medicare publishes about two years behind.

Provenance

Source: CMS Medicare Part D Prescribers by Provider and Drug · data year 2024

We reproduce what CMS published. We do not verify, edit or correct the underlying records.

A prescription record is not evidence of wrongdoing, and nothing here is medical advice. Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency.

How to dispute or correct a record